U.S. Blood Screening Market to 2032
Overview
The U.S. Blood Screening Market is expected to reach a 2.13 USD Billion by 2032 and is projected to grow at a CAGR of 12.92% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.00
Forecast, 2032 (USD Billion)
2.13
CAGR, 2024 - 2032
12.92%
Report Coverage
U.S.
U.S. Blood Screening Market 2018-2032 USD Billion
U.S. Blood Screening Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.00 USD Billion
- Projected Market Size (2032): 2.13 USD Billion
- CAGR (2025-2032): 12.92%
Key Findings of U.S. Blood Screening Market
- The U.S. Blood Screening Market was valued at 1.00 USD Billion in 2024.
- The U.S. Blood Screening Market is likely to grow at a CAGR of 12.92% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Reagents & Kits in Products & Services Segment accounted for the largest share of the market with a revenue of 0.47 USD Billion
- The fastest growing segment Diagnostic Centers in End User Segment grew Fastest with a CAGR of 14.02% during the forecast period from 2024 to 2032.
U.S. Blood Screening Market Scope
U.S. Blood Screening Market Segmentation & Scope
Products & Services
- Software & Services
- Instruments
- Reagents & Kits
Technology
- Others
- Western Blot Assay
- Nucleic Acid Test
- Next-Generation Sequencing (NGS)
- Rapid Tests
- Enzyme-Linked Immunosorbent Assay (ELISA)
Disease Type
- Others
- HIV/AIDS
- Respiratory Diseases
- Infectious Diseases
- Cholesterol
- Cold & Flu
- Diabetes Mellitus
- Oncology
End User
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Blood Bank
- Diagnostic Centers
U.S. Blood Screening Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.00 USD Billion |
| Market Value in 2032 | 2.13 USD Billion |
| CAGR (2025-2032) | 12.92% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Products & Services,Technology,Disease Type,End User |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 1.00 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,001.98 USD Million in 2024.
Segments and Scope
-
U.S. Blood Screening Market to 2032, By Products & Services
- Reagents & Kits is the largest segment in U.S. Blood Screening Market to 2032 with a revenue of 469.72 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in U.S. Blood Screening Market to 2032 with a Growth rate of 12.42 % in forecast period 2025-2032.
-
U.S. Blood Screening Market to 2032, By Technology
- Enzyme-Linked Immunosorbent Assay (ELISA) is the largest segment in U.S. Blood Screening Market to 2032 with a revenue of 273.14 USD Billion in the year 2024.
- Next-Generation Sequencing (NGS) is the Fastest growing segment in U.S. Blood Screening Market to 2032 with a Growth rate of 13.25 % in forecast period 2025-2032.
-
U.S. Blood Screening Market to 2032, By Disease Type
- Oncology is the largest segment in U.S. Blood Screening Market to 2032 with a revenue of 218.87 USD Billion in the year 2024.
- Oncology is the Fastest growing segment in U.S. Blood Screening Market to 2032 with a Growth rate of 13.89 % in forecast period 2025-2032.
-
U.S. Blood Screening Market to 2032, By End User
- Diagnostic Centers is the largest segment in U.S. Blood Screening Market to 2032 with a revenue of 279.08 USD Billion in the year 2024.
- Diagnostic Centers is the Fastest growing segment in U.S. Blood Screening Market to 2032 with a Growth rate of 14.02 % in forecast period 2025-2032.
U.S. Blood Screening Market Company Share Analysis
| Company Name |
|
||
| INNOVUS PHARMACEUTICALS, INC. | |||
| Pfizer Inc. | |||
| Bayer AG | |||
| Cipla Inc. | |||
| GSK plc. | |||
U.S. Blood Screening Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Blood Screening Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Blood Screening Market is segmented based on Segmentation Products & Services,Technology,Disease Type,End User.
U.S. Blood Screening Market was valued at USD 1.00(Revenue in USD Billion) in 2022.
U.S. Blood Screening Market is projected to grow at a CAGR of 12.92% during the forecast period of 2024 to 2032.
The Reagents & Kits segment is expected to dominate the U.S. Blood Screening Market, holding a largest market share of 0.47 USD Billion in 2024
U.S. Blood Screening Market Scope
U.S. Blood Screening Market Segmentation & Scope
Products & Services
- Software & Services
- Instruments
- Reagents & Kits
Technology
- Others
- Western Blot Assay
- Nucleic Acid Test
- Next-Generation Sequencing (NGS)
- Rapid Tests
- Enzyme-Linked Immunosorbent Assay (ELISA)
Disease Type
- Others
- HIV/AIDS
- Respiratory Diseases
- Infectious Diseases
- Cholesterol
- Cold & Flu
- Diabetes Mellitus
- Oncology
End User
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Blood Bank
- Diagnostic Centers
Frequently Asked Questions
The U.S. Blood Screening Market is segmented based on Segmentation Products & Services,Technology,Disease Type,End User.
U.S. Blood Screening Market was valued at USD 1.00(Revenue in USD Billion) in 2022.
U.S. Blood Screening Market is projected to grow at a CAGR of 12.92% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Blood Screening Market for final year is USD 2.13 (USD Billion).
U.S. Blood Screening Market Company Profiling
Frequently Asked Questions
The U.S. Blood Screening Market is segmented based on Segmentation Products & Services,Technology,Disease Type,End User.
U.S. Blood Screening Market was valued at USD 1.00(Revenue in USD Billion) in 2022.
U.S. Blood Screening Market is projected to grow at a CAGR of 12.92% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Blood Screening Market for final year is USD 2.13 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.